BIOMAT Database Logo BIOMAT Database Logo

5-HT1A-versus D2-receptor selectivity of flesinoxan and analogous N4-substituted N1-arylpiperazines. 1997

W Kuipers, and C G Kruse, and I van Wijngaarden, and P J Standaar, and M T Tulp, and N Veldman, and A L Spek, and A P IJzerman
Department of Medicinal Chemistry, Solvay Pharmaceuticals Research Laboratories, DA Weesp, The Netherlands. kuipers-solvay@e-mail.com

We investigated the structural requirements for high 5-HT1A affinity of the agonist flesinoxan and its selectivity versus D2 receptors. For this purpose a series of arylpiperazine congeners of flesinoxan were synthesized and evaluated for their ability to displace [3H]-8-OH-DPAT and [3H]spiperone from their specific binding sites in rat frontal cortex homogenates and rat striatum, respectively. Variations were made in the N4-substituent and the arylpiperazine region. Effects of N4-substitution in the investigated compounds appeared to be quite similar for 5-HT1A- and D2-receptor affinity. Lipophilicity at a distance of four carbon atoms from the piperazine N4 atom seems to be the main contributing factor to affinity for both receptors. Our data show that the amide group in the flesinoxan N4-substituent is unlikely to interact with the 5-HT1A receptor but, instead, acts as a spacer. In contrast to the structure-affinity relationships (SARs) of the N4-substituents, selectivity for 5-HT1A versus D2 receptors was gained by the arylpiperazine substitution pattern of flesinoxan. Restriction of flexibility of the N4-(benzoylamino)ethyl substituent and its effect on 5-HT1A-receptor affinity and activity were also studied. Our data show that in the bioactive conformation, the N4-[(p-fluorobenzoyl)amino]ethyl substituent is probably directed anti-periplanar relative to the HN4 atom. These results were used to dock flesinoxan (1) and two of its congeners (27 and 33) into a model of the 5-HT1A receptor that we previously reported. Amino acid residues surrounding the N4-[(p-fluorobenzoyl)amino]ethyl substituent of flesinoxan and its congeners are also present in D2 receptors. In contrast, several residues that contact the benzodioxane moiety differ from those in D2 receptors. These observations from the 3D model agree with the 5-HT1A SAR data and probably account for the selectivity of flesinoxan versus D2 receptors.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011985 Receptors, Serotonin Cell-surface proteins that bind SEROTONIN and trigger intracellular changes which influence the behavior of cells. Several types of serotonin receptors have been recognized which differ in their pharmacology, molecular biology, and mode of action. 5-HT Receptor,5-HT Receptors,5-Hydroxytryptamine Receptor,5-Hydroxytryptamine Receptors,Receptors, Tryptamine,Serotonin Receptor,Serotonin Receptors,Tryptamine Receptor,Tryptamine Receptors,Receptors, 5-HT,Receptors, 5-Hydroxytryptamine,5 HT Receptor,5 HT Receptors,5 Hydroxytryptamine Receptor,5 Hydroxytryptamine Receptors,Receptor, 5-HT,Receptor, 5-Hydroxytryptamine,Receptor, Serotonin,Receptor, Tryptamine,Receptors, 5 HT,Receptors, 5 Hydroxytryptamine
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein

Related Publications

W Kuipers, and C G Kruse, and I van Wijngaarden, and P J Standaar, and M T Tulp, and N Veldman, and A L Spek, and A P IJzerman
Characterization of potent and selective antagonists at postsynaptic 5-HT1A receptors in a series of N4-substituted arylpiperazines.
September 1995, Journal of medicinal chemistry,
W Kuipers, and C G Kruse, and I van Wijngaarden, and P J Standaar, and M T Tulp, and N Veldman, and A L Spek, and A P IJzerman
Theoretical descriptors in quantitative structure-affinity and selectivity relationship study of potent N4-substituted arylpiperazine 5-HT1A receptor antagonists.
May 1998, Bioorganic & medicinal chemistry,
W Kuipers, and C G Kruse, and I van Wijngaarden, and P J Standaar, and M T Tulp, and N Veldman, and A L Spek, and A P IJzerman
N4-substituted N1-toluenesulfonylpiperazines.
January 1968, Journal of medicinal chemistry,
W Kuipers, and C G Kruse, and I van Wijngaarden, and P J Standaar, and M T Tulp, and N Veldman, and A L Spek, and A P IJzerman
Structural determinants of 5-HT1A versus 5-HT1D receptor binding site selectivity.
February 1991, European journal of pharmacology,
W Kuipers, and C G Kruse, and I van Wijngaarden, and P J Standaar, and M T Tulp, and N Veldman, and A L Spek, and A P IJzerman
Effects of the 5-HT1A receptor agonist flesinoxan in panic disorder.
September 1996, Psychopharmacology,
W Kuipers, and C G Kruse, and I van Wijngaarden, and P J Standaar, and M T Tulp, and N Veldman, and A L Spek, and A P IJzerman
N4-(Biguanidyl-substituted)-N1-benzoyl sulphanilamides.
October 1950, Current science,
W Kuipers, and C G Kruse, and I van Wijngaarden, and P J Standaar, and M T Tulp, and N Veldman, and A L Spek, and A P IJzerman
Synthesis of certain N1- and N4-(5-nitro-2-pyridyl)-substituted sulfonamides.
July 1969, Journal of pharmaceutical sciences,
W Kuipers, and C G Kruse, and I van Wijngaarden, and P J Standaar, and M T Tulp, and N Veldman, and A L Spek, and A P IJzerman
Arylpiperazines with N-acylated amino acids as 5-HT1A receptor ligands.
July 2006, Bioorganic & medicinal chemistry letters,
W Kuipers, and C G Kruse, and I van Wijngaarden, and P J Standaar, and M T Tulp, and N Veldman, and A L Spek, and A P IJzerman
The flesinoxan 5-HT1A receptor challenge in major depression and suicidal behavior.
October 1995, Pharmacopsychiatry,
W Kuipers, and C G Kruse, and I van Wijngaarden, and P J Standaar, and M T Tulp, and N Veldman, and A L Spek, and A P IJzerman
The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
May 1997, European journal of pharmacology,
Copied contents to your clipboard!